Vaxil Bio Ltd (VXL) — Cash Flow Reinvestment Rate
Latest as of December 2017:
0.00x
Vaxil Bio Ltd (VXL) has a Cash Flow Reinvestment Rate of 0.00x as of December 2017, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$441.00K. Check Vaxil Bio Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
CA$0.00
Capex + Investments
Operating Cash Flow
CA$441.00K
CAD
Capital Expenditures
CA$0.00
CAD
Annual Cash Flow Reinvestment Rate for Vaxil Bio Ltd (None–None)
Year-by-year capital reinvestment analysis for Vaxil Bio Ltd. For live market cap and broader valuation context, see Vaxil Bio Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow